Multiplex Molecular in vitro Diagnostics
The IntelliPlex™ SARS-CoV-2 detection platform provides an automated solution to address the urgent need for the high-volume testing during the Coronavirus disease 2019 (COVID-19) pandemic.
The IntelliPlex™ SARS-CoV-2 kit is a molecular in vitro diagnostic test that aids in the detection and diagnosis COVID-19 and is based on widely used nucleic acid amplification technology.
The IntelliPlex™ SARS-CoV-2 Detection Kit detects the presence of N, RdRp, and E genes of SARS-CoV-2 in RNA extracted from respiratory specimen.
• Simultaneously detect 3 genes (E, N, and RdRp) in SARS-CoV-2 to minimize the probability of false negative test results due to the fast-evolving pace of this virus
• Process up to 564 samples in 9 hours. (96 rxns/kit)
• High sensitivity (140 copies/mL)
2-3 Week Installation
FDA EUA, CE-IVD